Ted James, MD, MS, FACS
Vice Chair Academic Affairs
Chief of Breast Surgical Oncology
Beth Israel Deaconess Medical Center
Harvard Medical School
A member of the BIDMC/Harvard health system, Dr. Ted James manages the surgical care of breast cancer patients. He performs advanced breast surgical oncology procedures including oncoplastic and minimally invasive breast surgery. Dr. James also takes an active role promoting quality initiatives in cancer care delivery. He is active in research on improving outcomes in breast cancer surgery, including margin control during breast conserving surgery.
Dr. James employs a multidisciplinary, team-based approach to cancer care and believes that patients should be key members of the treatment decision-making process. He educates patients about their diagnosis and addresses their treatment priorities. He believes that care must also be compassionate and focus on the entire person including their physical, emotional and spiritual well-being.
In addition to his medical and surgical training, Dr. James obtained a Health Care Management degree from Harvard. Dr. James is also faculty at Harvard Medical School and serves in leadership roles with the Commission on Cancer and American Cancer Society. He is a fellow of the American College of Surgeons and member of the Society of Surgical Oncology and American Society of Breast Surgeons.
Frank Prendergast, MD
Mayo Clinic Comprehensive Cancer Center
Dr. Prendergast has held senior positions within Mayo Clinic: Chair, Department of Biochemistry & Molecular Biology; Director for Research, Mayo Clinic Rochester,‘89-‘92. Member of the Board of Governors for Mayo Clinic in Rochester; Mayo Clinic Board of Trustees,‘92-‘09; Mayo Clinic’s Board of Governors, ‘99-‘06. Mayo Distinguished Investigator, Emeritus Director of the Mayo Clinic Comprehensive Cancer Center and Emeritus Director of Mayo Center for Individualized Medicine.
Frank also served extensively for the National Institutes of Health, Board of Advisors for Division of Research Grants; National Advisory General Medical Sciences Council; Board of Scientific Advisors of National Cancer Institute; National Cancer Advisory Board.
He has received the following honors and awards: Rhodes Scholarship; DSc Purdue University and University West Indies, Outstanding Graduate from University West Indies; Outstanding Graduate College of Biological Sciences from University of Minnesota; Musgrave Gold Medal Institute of Jamaica.
Frank holds a medical degree with honors from University of West Indies; Oxford University Rhodes Scholar M.A. degree in physiology. After internal medicine residency at Mayo Clinic, he obtained the Ph.D. degree in biochemistry at University of Minnesota/Mayo Graduate School.
Juliann Reiland, MD, FACS
Chair, ASBrS Oncoloplastic Surgery Work Group
Avera, University of South Dakota Sanford School of Medicine, Vermillion, Medical School
Dr. Reiland is a board certified surgeon specializing in breast cancer surgery with an emphasis in oncoplastic surgery and IOERT procedures. Dr. Reiland is currently the Medical Director of Avera McKennan’s IOERT Breast Program. She has had 23 years of surgical experience, with more than 11 years dedicated exclusively to breast surgery. Dr. Juliann’s passion for Breast Conserving Surgery is well known. She is a prominent speaker both Nationally and Internationally regarding surgical approaches to breast cancer for the best clinical and cosmetic results. She has incorporated the most advanced approaches for breast cancer treatment, including sentinel node biopsy, accelerated partial breast radiation and oncoplastic surgical techniques.
Brian Wilson, PHD
Head, Div of Biophysics & imaging, Ontario Cancer Institute, Princess Margaret Cancer Center
Dr. Wilson leads an internationally recognized R&D program in optics-based biomedical applications, with a primary translational / clinical focus. Dr. Wilson has published over 300 peer-reviewed papers in basic, translational and clinical research, and has trained more than 60 graduate students and postdoctoral and clinical fellows. He holds or has held several international Visiting Appointments (Harvard, USA; Saõ Paulo, Brazil; Fujian, China; Western Australia) and is involved in many national and international collaborations.
Gordon Cheung, MD
Radiologist, Medical Director of MRI/CT at CML Healthcare
Dr. Cheung is Medical Director of MRI/CT at CML HealthCare, one of the largest medical imaging practices in Canada. He is Consultant in Medical Imaging, Division of Neuroradiology and Interventional Neuroradiology at Sunnybrook Health Sciences Center; and Assistant Professor at the University of Toronto. From 1990 to 2003, Dr. Cheung was the Clinical Director of MRI at Sunnybrook Health Sciences Center. Dr. Cheung is also an entrepreneur, a founding partner of TUC Managed IT Solutions, and a founder of Excelion Technology.
Charles S. Carignan, MD
Former Founder and CEO of NinePoint Medical, and Chief Medical Officer of Novasys Medical Inc, the CMO of Boston Scientific
Dr. Carignan has more than twenty (20) years of experience in medical device development and holds vast experience as a Clinician, Med-Tech Executive and Chief Executive Officer. He also has strong regulatory and reimbursement experience. Dr. Carignan holds a Bachelor Degree from Yale University and obtained his Doctor of Medicine (M.D) from Columbia University in 1991. He trained in General Surgery at Columbia Presbyterian Medical Center.
Most recently Dr. Carignan held the position of CEO at Rex Bionics Pty Limited. Prior to this, Dr. Carignan held the position of CEO at BionX Medical Technologies (now part of Ottobock) from July 2014 to March 2017. Previously Dr. Carignan was the Founder and CEO of NinePoint Medical, an OCT-based imaging technology initially used to image pathology in the esophagus, the Chief Medical Officer of Novasys Medical Inc, the CMO of Boston Scientific, and the VP of Medical Affairs at Conceptus, acquired by Bayer.